ArticleAesthetic plastic surgery2026
COVID-19-Related Immune Activation and Capsular Contracture: A Cohort Study of Infection, Vaccination, and Explantation.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCapsular contracture, a prevalent complication following breast augmentation, is characterized by pain, implant distortion, and often necessitates explantation. While its multifactorial pathogenesis involves bacterial biofilms and implant characteristics, the influence of immune activation, particularly in the context of COVID-19 infection and vaccination, remains underexplored. Growing evidence suggests COVID-19 vaccination can trigger immune-mediated reactions, including delayed inflammatory responses to dermal fillers. Given that capsular contracture is a fibro-inflammatory response, this study investigated whether COVID-19-related immune activation influenced the time from breast implantation to explantation due to severe capsular contracture.
methodsThis retrospective cohort study analyzed patients from a single private practice who underwent breast implant removal due to Baker grade III or IV capsular contracture. Two historical cohorts were compared: Cohort 1 (pre-pandemic: January 2016 - December 2019) and Cohort 2 (post-pandemic: January 2021 - December 2024).The primary outcome, time from implantation to explantation, was analyzed using Kaplan-Meier survival curves, log-rank tests, and a multivariate Cox proportional hazards model, adjusting for confounders. Ethical approval was obtained (CAAE: 35154720.2.0000.5330).
resultsA total of 115 patients were included (47 in Cohort 1, 68 in Cohort 2). Baseline characteristics were comparable between groups. The time from breast implantation to explantation due to Baker grade III/IV capsular contracture was significantly shorter in the post-pandemic cohort (4.9 ± 1.3 years) compared to the pre-pandemic cohort (8.2 ± 1.5 years, p < 0.001). The Kaplan-Meier estimated median time to explantation was 5.0 years (95% CI: 4.6-5.3) for the post-pandemic cohort versus 8.0 years (95% CI: 7.6-8.4) for the pre-pandemic cohort (p < 0.001). Multivariate Cox analysis showed a hazard ratio of 2.3 (95% CI: 1.5-3.5, p < 0.001) for earlier explantation in the post-pandemic cohort, independent of confounders. No significant differences were found in the proportion of Baker IV contractures or primary complaints.
conclusionWhile this study does not establish causation, the observed reduction in the time to explantation in the post-pandemic cohort compared to the pre-pandemic cohort suggests that external factors, including potential immunological responses to the COVID-19 vaccine or infection, may have influenced the progression of capsular contracture. This information is relevant for clinical practice and has implications for patient management, informed consent, and medicolegal assessment of implant-related complications. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.